Residents Rate Enjoyment of Teaching As Key for ICU Doctors

This article originally appeared here.
Share this content:
Residents Rate Enjoyment of Teaching As Key for ICU Doctors
Residents Rate Enjoyment of Teaching As Key for ICU Doctors

WEDNESDAY, April 12, 2017 (HealthDay News) -- Behaviors that residents value in intensive care unit (ICU) attending physicians include enjoyment of teaching and treatment of patients, families, and non-physician staff, according to a study published in the April issue of the Annals of the American Thoracic Society.

Lekshmi Santhosh, M.D., from the University of California at San Francisco, and colleagues surveyed internal medicine residents regarding the importance of behaviors of ICU attending physician role models using a 37-item questionnaire. The questionnaire included behaviors that residents observed in ICU attending physicians. Two hundred sixty residents responded to the survey.

The researchers found that enjoyment of teaching, demonstrating empathy and compassion to patients and families, the ability to explain clinical reasoning and differential diagnosis, respectful treatment of non-physician staff members, and enthusiasm on rounds were the behaviors most commonly rated as very important to residents. Trainees rated having numerous research publications, having served as chief resident, sharing personal life events, and organizing end-of-rotation social events as less important.

"Our study provides new information to attending physicians striving to influence resident education," the authors write. "We discovered that behaviors, such as expression of empathy, explanation of clinical reasoning, and qualities of professionalism, were commonly seen in esteemed teaching attending physician."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths